# Mesenchymal Stem Cells Transplantation for Liver Cirrhosis Due to HCV Hepatitis

> **NCT02705742** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Saglik Bilimleri Universitesi Gulhane Tip Fakultesi** · enrollment: 5 (estimated)

## Conditions studied

- Liver Cirrhosis

## Interventions

- **BIOLOGICAL:** Mesenchymal Stem Cells

## Key facts

- **NCT ID:** NCT02705742
- **Lead sponsor:** Saglik Bilimleri Universitesi Gulhane Tip Fakultesi
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2017-07
- **Final completion:** 2017-12
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2016-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02705742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02705742, "Mesenchymal Stem Cells Transplantation for Liver Cirrhosis Due to HCV Hepatitis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02705742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
